Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Cardiovascular diseases Stories

2014-04-14 12:32:47

SAN CLEMENTE, Calif., April 14, 2014 /PRNewswire/ -- ROX Medical today announced it has completed enrollment for CONTROL-HTN trial, an international multi center, prospective, randomized, controlled, blinded endpoint trial of the ROX Coupler for the treatment of arterial hypertension. The CONTROL-HTN trial, NCT01642498, is evaluating the safety and efficacy of a percutaneous procedure creating a fixed connection between a central artery and vein in the upper leg - for the treatment...

2014-03-12 23:04:39

The global market for peripheral vascular surgical devices was valued at $5.8 billion in 2012 and at $6.2 billion for 2013. BCC Research expects the market to grow to $8.4 billion by 2018, and register a five-year compound annual growth rate of 6.3% from 2013 to 2018. Wellesley, Mass. (PRWEB) March 12, 2014 According to a new technical market research report Peripheral Vascular Surgical Devices: Technologies and Global Markets, from BCC Research (http://www.bccresearch.com), the global...

2014-03-04 16:12:53

Noninvasive imaging of carotid artery plaque with MRI can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular disease, according to a new study published online in the journal Radiology. Researchers have long known that some arterial plaque is more dangerous because of its vulnerability to rupture. MRI can discern features of vulnerable plaque, such as a lipid core with a thin fibrous cap. This ability makes MRI a...

2014-03-03 23:00:09

Noninvasive imaging of carotid artery plaque with MRI can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular disease, according to a new study published online, March 4, in the journal Radiology. Oak Brook, Ill. (PRWEB) March 03, 2014 Noninvasive imaging of carotid artery plaque with MRI can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular...

2014-02-03 23:03:11

AtCor Medical's Noninvasive Central Aortic Blood Pressure and Arterial Stiffness Technology Now Available in Canada Itasca, IL (PRWEB) February 03, 2014 AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor® system which measures central aortic blood pressures and arterial stiffness noninvasively, today announced that its SphygmoCor XCEL system has been approved by Health Canada, allowing AtCor to sell its new system to Canadian customers. Canada’s population...

2013-11-18 08:29:00

ChanRx Presents Study Results at 2013 American Heart Association Scientific Sessions DALLAS, Nov. 18, 2013 /PRNewswire/ -- ChanRx, a pharmaceutical company developing medicines for cardiovascular diseases, today announced positive safety and statistically significant efficacy data from a Phase IIb study of vanoxerine (GBR-12909), a drug in development for the treatment of atrial fibrillation. The data were presented yesterday at the American Heart Association 2013 Scientific...

2013-11-15 04:21:05

DARMSTADT, Germany and NANTONG, China, November 15, 2013 /PRNewswire/ -- - EUR 80 million investment underscores Merck's long-term commitment to China - New facility will focus on Merck's leading brands referenced in China's essential drug list and serve the country's expanding healthcare needs in the areas of diabetes, cardiovascular diseases and thyroid disorders Merck announced today a EUR 80 million investment in a...

2013-11-07 23:29:08

“First Contact-to-Balloon” Initiative Accelerates Patient Diagnosis, Empowers EMS to Activate Hospital Cardiac Teams Pittsburgh PA (PRWEB) November 07, 2013 When a heart attack strikes, time is never on the victim’s side. Without swift treatment to restore blood flow to the heart, a patient’s chances of survival or escaping serious cardiovascular injury diminish by the minute. That’s particularly true for a dangerous type of heart attack called ST-elevation myocardial...

2013-11-05 16:25:53

IRVINE, Calif., Nov. 5, 2013 /PRNewswire/ -- Dr. Doug Harrington, clinical professor at USC Keck School of Medicine, presented "Why Do Heart Attacks Happen to 'Healthy People'?" on behalf of nonprofit, GUARDaHEART at both the 13(th) Annual Maui Cardiovascular Symposium and at the 5th Annual Orange County Symposium. (Logo: http://photos.prnewswire.com/prnh/20130319/LA79677LOGO) (Logo: http://photos.prnewswire.com/prnh/20130821/LA67312LOGO) Dr. Harrington's presentations addressed...

2013-10-15 08:30:19

IRVINE, Calif., Oct. 15, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Erik SG Stroes, MD, Chair and Professor at the Department of Vascular Medicine at the Academic Medical Center (AMC), Amsterdam has joined the Company as a member of the Clinical Advisory Board. "We are pleased to announce that Dr. Stroes...